Allergy and breathing problems in babies at 12 months
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study follows full-term babies from birth to 12 months to see if allergies affect breathing problems. It may help doctors understand and prevent respiratory issues in infants.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be born full-term (at least 37 weeks of pregnancy).
- Your baby must be born at Amiens Picardie University Hospital.
- You (the mother) must be at least 18 years old and able to understand, read, and speak French, or have someone close who can help with translation.
- You must be enrolled in the French social security system.
- Your baby must not be from a multiple pregnancy (like twins or triplets).
- Your baby must not have any birth defects found before or right after birth.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how indoor air pollution affects children's health. It compares children with allergies or asthma to those without, to see if air quality plays a role.
This study looks at the natural bacteria and germs in a premature baby's airways to see if they can help predict whether the baby will develop a lung problem called bronchopulmonary dysplasia (BPD). The goal is to find early clues that help doctors take better care of these babies.
This study follows newborns for two years to see how their immune system develops, especially if they have a family history of eczema, asthma, or hay fever. Researchers want to learn if certain immune markers appear early in babies who later develop eczema.
This study looks at young children's medical records to find early warning signs of asthma. It could help doctors identify asthma sooner and start treatment earlier.
This study looks at the bacteria (microbiome) in the airways of infants under 2 years old with severe asthma. It aims to understand how these bacteria might affect the disease.
This study looks at how newborns’ bodies are affected by COVID-19 around birth and whether a breathing support treatment (inhaled nitric oxide) changes outcomes. It also compares COVID-exposed babies and a similar group of babies without COVID who are not receiving the breathing treatment.
Hear when a new Allergy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.